Post COVID-19 Vaccine-associated Complications

Article Sidebar

PDF
Published: Feb 9, 2023
DOI: https://doi.org/10.58999/cijmr.v1i03.35
Keywords:
COVID-19, Case Series, COVID19 Vaccine, COVID19 Vaccine complications
Dimensions Badge

Main Article Content

Ajay Prakash Tripathi
Department of Medicine, RDGMC, Ujjain, Madhya Pradesh, India
Ashish Sharma
Department of Medicine RDGMC Ujjain, Madhya Pradesh,India
Dr Himanshu Jain
Chandrakant Salve
Departmet of Medicine RDGMC Ujjain ,Madhya Pradesh,India
Dr Aayush Malik
Tejaswini Dwivedi
Department of Medicine RD Gardi Medical college Ujjain Madhya Pradesh, India

Abstract

The COVID-19 pandemic is being fought against worldwide; the major weapon against this pandemic
has been the vaccine against it. There are reports of neurological complications and sequelae after
COVID-19 vaccinations, some cases with ChAdOx1 nCov-19 is adenovirus vector-based vaccines. In
India vaccination program against covid19 is using this vaccine by this vaccine. Reports of vaccineassociated side effects have emerged, which are rare but serious. This case series presents a few such cases reported in our hospitals:- RD Gardi Medical college (CR Gardi Hospital, Ujjain) and Charitable trust Hospital, Ujjain.

Article Details

How to Cite
Tripathi, A. P., Sharma, A. ., Dr Himanshu Jain, Salve, C., Dr Aayush Malik, & Dwivedi, T. (2023). Post COVID-19 Vaccine-associated Complications. Central India Journal of Medical Research, 1(03). https://doi.org/10.58999/cijmr.v1i03.35
Issue
Vol. 1 No. 03 (2022): Central India Journal of Medical Research
Section
Case Report

References

References

Greinacher A, Thiele T, Warkentin TE, Weisser K, Kyrle PA, Eichinger S. Thrombotic Thrombocytopenia after ChAdOx1 nCov-19 Vaccination. N Engl J Med. 2021;384:2092–101. doi:10.1056/NEJMoa2104840.

Greinacher A, Selleng K, Wesche J, Handtke S, Palankar R, Aurich K, et al. Towards Understanding ChAdOx1 nCov-19 Vaccine-induced Immune Thrombotic Thrombocytopenia (VITT) 2021. doi:10.21203/rs.3.rs-440461/v1.

Scully M, Singh D, Lown R, Poles A, Solomon T, Levi M, et al. Pathologic Antibodies to Platelet Factor 4 after ChAdOx1 nCoV-19 Vaccination. N Engl J Med. 2021;384:2202–11. doi:10.1056/NEJMoa2105385.

Gabarin N, Patterson S, Pai M, Afzaal T, Nazy I, Sheppard J-A, et al. Venous Thromboembolism and Mild Thrombocytopenia after ChAdOx1 nCoV-19 Vaccination. Thromb Haemost 2021. doi:10.1055/a-1585-6182.

Pomara C, Sessa F, Ciaccio M, Dieli F, Esposito M, Garozzo SF, et al. Post-mortem findings in vaccine-induced thrombotic thombocytopenia. Haematologica. 2021;106:2291–3. doi:10.3324/haematol.2021.279075.

Lo GK, Juhl D, Warkentin TE, Sigouin CS, Eichler P, Greinacher A. Evaluation of pretest clinical score (4 T's) for the diagnosis of heparin-induced thrombocytopenia in two clinical settings. J Thromb Haemost. 2006;4:759–65. doi:10.1111/j.1538-7836.2006.01787.x.

Pavord S, Scully M, Hunt BJ, Lester W, Bagot C, Craven B, et al. Clinical Features of Vaccine-Induced Immune Thrombocytopenia and Thrombosis. N Engl J Med 2021. doi:10.1056/NEJMoa2109908.

Abdalkader M, Shaikh SP, Siegler JE, Cervantes-Arslanian AM, Tiu C, Radu RA, et al. Cerebral Venous Sinus Thrombosis in COVID-19 Patients: A Multicenter Study and Review of Literature. Journal of Stroke and Cerebrovascular Diseases. 2021;30:105733. doi:10.1016/j.jstrokecerebrovasdis.2021.105733.

Kow CS, Hasan SS. Cerebral venous thrombosis following COVID-19 vaccination. J Stroke Cerebrovasc Dis. 2021:105866. doi:10.1016/j.jstrokecerebrovasdis.2021.105866.

Cines DB, Bussel JB. SARS-CoV-2 Vaccine–Induced Immune Thrombotic Thrombocytopenia. N Engl J Med. 2021;384:2254–6. doi:10.1056/NEJMe2106315.

Pottegård A, Lund LC, Karlstad Ø, Dahl J, Andersen M, Hallas J, et al. Arterial events, venous thromboembolism, thrombocytopenia, and bleeding after vaccination with Oxford-AstraZeneca ChAdOx1-S in Denmark and Norway: population based cohort study. BMJ. 2021;373:n1114. doi:10.1136/bmj.n1114.

Lee E-J, Cines DB, Gernsheimer T, Kessler C, Michel M, Tarantino MD, et al. Thrombocytopenia following Pfizer and Moderna SARS-CoV-2 vaccination. Am J Hematol. 2021;96:534–7. doi:10.1002/ajh.26132.

Schultz NH, Sørvoll IH, Michelsen AE, Munthe LA, Lund-Johansen F, Ahlen MT, et al. Thrombosis and Thrombocytopenia after ChAdOx1 nCoV-19 Vaccination. N Engl J Med. 2021;384:2124–30. doi:10.1056/NEJMoa2104882.

Long B, Bridwell R, Gottlieb M. Thrombosis with thrombocytopenia syndrome associated with COVID-19 vaccines. The American Journal of Emergency Medicine. 2021;49:58–61. doi:10.1016/j.ajem.2021.05.054.

Juhl D, Eichler P, Lubenow N, Strobel U, Wessel A, Greinacher A. Incidence and clinical significance of anti-PF4/heparin antibodies of the IgG, IgM, and IgA class in 755 consecutive patient samples referred for diagnostic testing for heparin-induced thrombocytopenia. European Journal of Haematology. 2006;76:420–6. doi:10.1111/j.1600-0609.2005.00621.x.

Greinacher A. Heparin-Induced Thrombocytopenia. N Engl J Med. 2015;373:252–61. doi:10.1056/NEJMcp1411910.

Keddie S, Pakpoor J, Mousele C, et al. Epidemiological and cohort study finds no association between COVID-19 and Guillain-Barré syndrome. Brain. 2021;144(2):682-693. doi:10.1093/brain/awaa433

Waheed S, Bayas A, Hindi F, Rizvi Z, Espinosa PS. Neurological Complications of COVID-19: Guillain-Barre Syndrome Following Pfizer COVID-19 Vaccine. Cureus. 2021;13(2):e13426. Published 2021 Feb 18. doi:10.7759/cureus.13426

Waheed , carey et al, “Post COVID19 vaccine small fibre neuropathy.”

Anton Pottegård et al., “Arterial Events, Venous Thromboembolism, Thrombocytopenia, and Bleeding After Vaccination with Oxford-AstraZeneca ChAdOx1-S in Denmark and Norway: Population Based Cohort Study,” BMJ 373 (2021), https://doi.org/10.1136/bmj.n1114